Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

李偉平 (Wei-Ping Lee)

李偉平(Wei-Ping Lee)圖 Return Appointment First Appointment

[Profile]

  • Education
    • 學士, 醫學系; 國防醫學院,
    • 博士, 美國德州大學(休士頓分校),
  • Career and Experience
    Current Positions：
    • - Now, 主治醫師, 醫學研究部, 臺北榮民總醫院,
    • - Now, 兼任主治醫師, 內科部胃腸肝膽科, 臺北榮民總醫院,
    • - Now, 兼任教授, 生化暨分子生物研究所, 國立陽明交通大學 ,
    Experiences：
    • - , 總醫師, 胃腸科, 臺北榮民總醫院,
    • - , 住院醫師, 內科部, 臺北榮民總醫院,
    • - , 住院醫師, 內科部, 林口長庚醫院,
    • - , 安德森癌症中心, 安德森癌症中心, 美國德州大學,
    • - , 助教, 生化學科, 國防醫學院,
  • Medical Expertise
    1. 肝膽胃腸疾病診斷及治療
    2. 腹部超音波及消化道內視鏡診斷及治療
  • License
    內科專科醫師 消化系醫學會 消化系內視鏡專科醫師
  • Language Expertise
    國語 英語

[Publications]

  1. Wang YK, Wang YW, Lu CL, Huang YH, Hou MC, Chang YL, Lee WP*, Lan KH. Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol. Scientific Report, 2022;12(1):9942.
  2. Lee WP*. Suppression of vacuolar-type ATPase and induction of endoplasmic reticulum stress by proton pump inhibitors. J Chin Med Assoc, 2022, in press.
  3. Wang YW, Lee WP, Huang YH, Hou MC, Lan KH. Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):984-995.
  4. Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus. J Chin Med Assoc. 2019;82:368-374.
  5. Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus. Am J Chin Med 2018;46:835-852.